Related Experiment Video
Updated: Aug 22, 2025
10:39
3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache
Published on: June 2, 2014
18.3K
Migraine and Gastroparesis.
Karissa N Arca1, Jacqueline Cai2, Fangfang Wang2
1Department of Neurology, Mayo Clinic Arizona, Scottsdale, AZ, USA. arca.karissa@mayo.edu.
Current Neurology and Neuroscience Reports
|November 12, 2022
Summary
Migraine and gastroparesis share overlapping pathophysiology and clinical features. Recognizing this connection is crucial for optimizing treatment strategies for patients experiencing both conditions.
Area of Science:
- Neurogastroenterology
- Neurology
- Gastroenterology
Background:
- Migraine is a prevalent, disabling neurological disorder.
- Gastroparesis is a gastrointestinal dysmotility disorder characterized by delayed gastric emptying.
- An increasing body of evidence suggests a significant overlap between migraine and gastroparesis.
Purpose of the Study:
- To review recent literature on the shared pathophysiology and clinical manifestations of migraine and gastroparesis.
- To highlight management considerations for patients with coexisting migraine and gastroparesis.
Main Methods:
- Literature review of recent studies on migraine and gastroparesis.
- Analysis of the interplay between central, autonomic, and enteric nervous systems.
- Examination of clinical presentations and treatment implications.
Main Results:
- Gastroparesis can occur during and between migraine attacks, affecting oral medication absorption.
- Autonomic nervous system dysfunction is a key feature in both conditions.
- Noninvasive vagus nerve stimulation shows promise for both migraine and gastroparesis.
Conclusions:
- The bidirectional gut-brain axis connection is critical in understanding migraine and gastroparesis.
- Management strategies must account for concurrent gastroparesis in migraine patients.
- Vagus nerve modulation represents a potential therapeutic target for both disorders.
Related Concept Videos
01:20Gastrointestinal Motility Disorders
551
Gastrointestinal or GI motility disorders are characterized by irregular gastrointestinal tract movements, disrupting food transit from the mouth to the anus. They are caused by damage or dysfunction in gut muscles or nerves. These disorders can cause symptoms such as severe constipation, diarrhea, abdominal pain, and swallowing difficulties. Disorders can affect any segment of the GI tract and range widely in severity, from common conditions like GERD to life-threatening conditions like...
551
01:28Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists
520
Prokinetic agents are specialized medications that stimulate gastrointestinal (GI) motility, promoting food movement through the GI tract. Dopamine, an inhibitory neurotransmitter, plays a significant role in this process, reducing GI motility and indirectly controlling the speed of digestion. Dopamine receptor antagonists, such as metoclopramide and domperidone, offer a unique advantage as prokinetic agents. By blocking the dopamine receptors, these drugs increase GI motility, improving food...
520
01:15Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding
250
Enteral nutrition encompasses various methods of delivering nutrition directly to the gastrointestinal (GI) tract, bypassing traditional oral intake. It is particularly beneficial for patients who cannot eat by mouth but have a functioning digestive system. Key methods include nasointestinal feeding, gastrostomy, and jejunostomy, each suited to different clinical scenarios based on the patient's needs and condition.
Nasointestinal Feeding
Nasointestinal feeding involves placing a tube...
Nasointestinal Feeding
Nasointestinal feeding involves placing a tube...
250
01:16Gastric Motility
986
Gastric motility is the coordinated contraction and relaxation of stomach muscles that convert ingested food into chyme, a semi-liquid substance ready for further digestion in the intestines. The process begins with the vagus nerve inducing the relaxation of the smooth muscles in the fundus and body of the stomach, allowing these regions to expand and accommodate up to approximately 1.5 liters of food and liquid.
Peristaltic Waves and Chyme Formation
Upon food entry, the stomach initiates...
Peristaltic Waves and Chyme Formation
Upon food entry, the stomach initiates...
986
01:23Gastritis III: Clinical Manifestations and Management
396
The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
396
01:22Pathophysiology of Vomiting
906
Vomiting is a complex physiological response to expel harmful or irritating substances from the body. It's a defensive mechanism triggered by stimuli like poisons, microbial toxins, cytotoxic drugs, and mechanical abdominal distension. The process is centrally coordinated by the vomiting (or emetic) center located in the medulla of the brainstem. This area, rich in muscarinic M1, histamine H1, neurokinin 1 (NK1), and serotonin 5-HT3 receptors, coordinates the act of vomiting through...
906